SpinalCyte rebrands to reflect focus on cell therapy treatments

Spinal Tech

SpinalCyte changed its name Jan. 28 to FibroGenesis.

Three insights:

1. The rebranding reflects the company's work with fibroblasts, which includes cell therapy treatments for chronic diseases and the development of a potential cure for degenerative disc disease.

2. The company has 180 issued and pending patents in a variety of areas, including disc degeneration, multiple sclerosis and Parkinson's.

3. FibroGenesis, completely funded by angel investors, will be wholly owned by SpinalCyte.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers